Investigating the Utility of Augmented Reality Assistance for Ultrasound-Guided Vascular Access
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- University of Alabama at Birmingham
- Study ID
- NCT07208071
- Status
- Recruiting
Conditions
- Vascular Access
Eligibility Criteria
- Sex
- ALL
- Age
- 5 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Augmented reality headset use — OTHERUse of a Microsoft HoloLens 2 headset with augmented reality assistance
Study Details
This study will investigate the benefits of augmented reality assistance on ultrasound-guided vascular access. Using the Microsoft HoloLens 2 headset, the investigators will study the benefits of augmented reality technology as a tool for improving the success rate, efficiency, and ease of access for peripheral venous catheters, peripherally inserted central venous catheters, and central venous catheters.
Key Dates
- Start date
- Jan 30, 2026
- Status verified
- Mar 2026
- Primary completion
- Jul 31, 2026
- Completion
- Jul 31, 2026
Study Design
- Enrollment
- 50 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- No Intervention: Control ArmProviders will not use augmented reality assistance when performing ultrasound-guided vascular access for this arm of the study
- Experimental: AR ArmProviders will use augmented reality assistance when obtaining ultrasound-guided vascular access
Primary Outcome Measure
Successful vascular access as indicated by blood return from the blood vessel and advancement of guide wire [ Time Frame: Up to 30 minutes ]
Central Contacts
- Jeffrey Coote Principal Investigator, MD5044817903
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35233 |
Find similar trials in Birmingham, AL
By research site